181 related articles for article (PubMed ID: 30938627)
1. VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.
Johnston EW; Bonet-Carne E; Ferizi U; Yvernault B; Pye H; Patel D; Clemente J; Piga W; Heavey S; Sidhu HS; Giganti F; O'Callaghan J; Brizmohun Appayya M; Grey A; Saborowska A; Ourselin S; Hawkes D; Moore CM; Emberton M; Ahmed HU; Whitaker H; Rodriguez-Justo M; Freeman A; Atkinson D; Alexander D; Panagiotaki E; Punwani S
Radiology; 2019 May; 291(2):391-397. PubMed ID: 30938627
[TBL] [Abstract][Full Text] [Related]
2. Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study.
Singh S; Rogers H; Kanber B; Clemente J; Pye H; Johnston EW; Parry T; Grey A; Dinneen E; Shaw G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Giganti F; Atkinson D; Moore CM; Whitaker HC; Alexander DC; Panagiotaki E; Punwani S
Radiology; 2022 Dec; 305(3):623-630. PubMed ID: 35916679
[TBL] [Abstract][Full Text] [Related]
3. Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefacts.
Singh S; Giganti F; Dickinson L; Rogers H; Kanber B; Clemente J; Pye H; Heavey S; Stopka-Farooqui U; Johnston EW; Moore CM; Freeman A; Whitaker HC; Alexander DC; Panagiotaki E; Punwani S
Eur J Radiol; 2023 Nov; 168():111109. PubMed ID: 37769532
[TBL] [Abstract][Full Text] [Related]
4. Microstructural characterization of normal and malignant human prostate tissue with vascular, extracellular, and restricted diffusion for cytometry in tumours magnetic resonance imaging.
Panagiotaki E; Chan RW; Dikaios N; Ahmed HU; O'Callaghan J; Freeman A; Atkinson D; Punwani S; Hawkes DJ; Alexander DC
Invest Radiol; 2015 Apr; 50(4):218-27. PubMed ID: 25426656
[TBL] [Abstract][Full Text] [Related]
5. Joint estimation of relaxation and diffusion tissue parameters for prostate cancer with relaxation-VERDICT MRI.
Palombo M; Valindria V; Singh S; Chiou E; Giganti F; Pye H; Whitaker HC; Atkinson D; Punwani S; Alexander DC; Panagiotaki E
Sci Rep; 2023 Feb; 13(1):2999. PubMed ID: 36810476
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient.
Donati OF; Mazaheri Y; Afaq A; Vargas HA; Zheng J; Moskowitz CS; Hricak H; Akin O
Radiology; 2014 Apr; 271(1):143-52. PubMed ID: 24475824
[TBL] [Abstract][Full Text] [Related]
7. Quantified analysis of histological components and architectural patterns of gleason grades in apparent diffusion coefficient restricted areas upon diffusion weighted MRI for peripheral or transition zone cancer locations.
Helfrich O; Puech P; Betrouni N; Pinçon C; Ouzzane A; Rizk J; Marcq G; Randazzo M; Durand M; Lakroum S; Leroy X; Villers A
J Magn Reson Imaging; 2017 Dec; 46(6):1786-1796. PubMed ID: 28383776
[TBL] [Abstract][Full Text] [Related]
8. Test-retest repeatability of ADC in prostate using the multi b-Value VERDICT acquisition.
Rogers HJ; Singh S; Barnes A; Obuchowski NA; Margolis DJ; Malyarenko DI; Chenevert TL; Shukla-Dave A; Boss MA; Punwani S
Eur J Radiol; 2023 May; 162():110782. PubMed ID: 37004362
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of prostate cancer lesions with high and with low Gleason score by diffusion-weighted MRI.
Barbieri S; Brönnimann M; Boxler S; Vermathen P; Thoeny HC
Eur Radiol; 2017 Apr; 27(4):1547-1555. PubMed ID: 27300199
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
11. The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone.
Chen Z; Xue Y; Zhang Z; Li W; Wen M; Zhao Y; Li J; Weng Z; Ye Q
Eur J Radiol; 2020 Apr; 125():108865. PubMed ID: 32058895
[TBL] [Abstract][Full Text] [Related]
12. Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists.
Antonelli M; Johnston EW; Dikaios N; Cheung KK; Sidhu HS; Appayya MB; Giganti F; Simmons LAM; Freeman A; Allen C; Ahmed HU; Atkinson D; Ourselin S; Punwani S
Eur Radiol; 2019 Sep; 29(9):4754-4764. PubMed ID: 31187216
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.
Salami SS; Ben-Levi E; Yaskiv O; Turkbey B; Villani R; Rastinehad AR
J Magn Reson Imaging; 2017 Feb; 45(2):610-616. PubMed ID: 27405584
[TBL] [Abstract][Full Text] [Related]
14. Diffusion Kurtosis Imaging Combined With DWI at 3-T MRI for Detection and Assessment of Aggressiveness of Prostate Cancer.
Wang X; Tu N; Qin T; Xing F; Wang P; Wu G
AJR Am J Roentgenol; 2018 Oct; 211(4):797-804. PubMed ID: 30085835
[TBL] [Abstract][Full Text] [Related]
15. Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.
Rosenkrantz AB; Triolo MJ; Melamed J; Rusinek H; Taneja SS; Deng FM
J Magn Reson Imaging; 2015 Mar; 41(3):708-14. PubMed ID: 24616064
[TBL] [Abstract][Full Text] [Related]
16. Time-Dependent Diffusion in Prostate Cancer.
Lemberskiy G; Rosenkrantz AB; Veraart J; Taneja SS; Novikov DS; Fieremans E
Invest Radiol; 2017 Jul; 52(7):405-411. PubMed ID: 28187006
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
18. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.
Gupta RT; Kauffman CR; Garcia-Reyes K; Palmeri ML; Madden JF; Polascik TJ; Rosenkrantz AB
AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283
[TBL] [Abstract][Full Text] [Related]
19. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the normal-to-diseased apparent diffusion coefficient ratio as an indicator of prostate cancer aggressiveness.
Lebovici A; Sfrangeu SA; Feier D; Caraiani C; Lucan C; Suciu M; Elec F; Iacob G; Buruian M
BMC Med Imaging; 2014 May; 14():15. PubMed ID: 24885552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
